|
| |
Nippon Shinyaku Company Limited Pages on BioPortfolio:
BioPortfolio - Nippon Shinyaku Company Limited - Profile
(http://www.bioportfolio.com/biocorporate/7585-Nippon+Shinyaku+Company+Limited. html). Contact Details:. 14 Nishinosho-Monguchi-cho Kisshoin,. Minami-ku ...
http://www.bioportfolio.com/biocorporate/7585-Nippon+Shinyak...
|
BioPortfolio - HISAMITSU PHARMACEUTICAL CO.LTD EMAIL AND FAX
Hisamitsu Pharmaceutical , Nippon Shinyaku Co., Ltd. Conclude Joint Development ... http://www.biospace.com/company_profile.aspx?CompanyId=83232. ...
http://www.bioportfolio.com/search/HISAMITSU_PHARMACEUTICAL_...
|
BioPortfolio - Oligoribonucleotides research
Direct Link, 1st October, 2008, Discovery Research Laboratories, Nippon Shinyaku Co., Ltd, 3-14-1 Sakura,. Chemical synthesis of oligoribonucleotides with ...
http://www.bioportfolio.com/indepth/Oligoribonucleotides/res...
|
BioPortfolio - Oligoribonucleotides - InDepth
Discovery Research Laboratories, Nippon Shinyaku Co., Ltd., Ibaraki,- Curr Protoc Nucleic Acid Chem. 2008 Sep;Chapter 2:Unit 2.15. (DOI Direct Link) ...
http://www.bioportfolio.com/indepth/Oligoribonucleotides.pdf...
|
BioPortfolio - actelion almorexant GSK
Actelion - The Company Pulmonary Arterial Hypertension. Actelion and GlaxoSmithKline enter into. almorexant collaboration. Actelion and Nippon
Shinyaku ...
http://www.bioportfolio.com/search/actelion_almorexant_GSK_....
|
Japanese Pharmaceutical Market, 2006-2011
Nippon Galen. Nippon Kayuku. Nippon Shinyaku. Nipro. Nitto Flour Milling. Novartis ... Company-wide Intranet Licence $9998.00 ...
http://www.bioportfolio.com/cgi-bin/acatalog/Japanese_Pharma...
|
La Merie R&D Pipeline News Therapeutic Edition Sample
A methyl-sulfonyl-acetamide. Nippon Shinyaku Co. Ltd. Small molecule. Pulmonary arte-rial hypertension + chronic thromboembolic pulmonary hypertension ...
http://www.bioportfolio.com/promote/Therapeutic%20Edition%20...
|
La Merie R&D Update: July 18, 2005
Company /. Represen-. tative. Product. Category. Indication. R&D. Stage. Message . A methyl-. sulfonyl-. acetamide. Nippon. Shinyaku Co. Ltd. Small. molecule ...
http://www.bioportfolio.com/pdf/R&D_Pipeline_News_Technology...
|
Results from other life science and pharmaceutical sites:
BioSpace - Nippon Shinyaku Co., Ltd. News, Search Jobs, Events
Hisamitsu Pharmaceutical , Nippon Shinyaku Co., Ltd. Conclude Joint Development Agreement For HFT-290 Cancer Pain Palliative Care Agent 10/19/2005 5:13:14 ...
http://www.biospace.com/company_profile.aspx?CompanyId=53021...
|
Roche - Roche and Nippon Shinyaku enter alliance to develop new ...
23 Oct 2003 ... Basel, Switzerland and Tokyo, Japan - Roche and Nippon Shinyaku Co., Ltd. today announced a strategic alliance to develop drug candidates ...
http://www.roche.com/med-cor-2003-10-23...
|
BioPortfolio - Nippon Shinyaku Company Limited - Profile
(http://www.bioportfolio.com/biocorporate/7585-Nippon+Shinyaku+Company+Limited. html). Contact Details:. 14 Nishinosho-Monguchi-cho Kisshoin,. Minami-ku ...
http://www.bioportfolio.com/biocorporate/7585-Nippon+Shinyak...
|
BioCentury - Nippon Shinyaku Co. Ltd. - Company Profile
Free access to this and other abridged company profiles is provided to all subscribers to SciBX: Science-Business eXchange. ...
http://www.biocentury.com/companies/Nippon_Shinyaku_Co_Ltd...
|
Bayer Yakuhin Ltd. To Transfer Baynas Marketing Rights To Nippon ...
Bayer Yakuhin Ltd. To Transfer Baynas Marketing Rights To Nippon Shinyaku Co., Ltd. 4/24/2006 Tokyo, Apr 24, 2006 (JCN) - Bayer Yakuhin and Nippon Shinyaku ...
http://www.biospace.com/news_story.aspx?NewsEntityId=16145...
|
Actelion - Actelion and Nippon Shinyaku to collaborate on novel ...
29 Feb 2008 ... Nippon Shinyaku Co., Ltd. Toshihiro Yoshioka General Manager of Corporate Communications Dept. +81 75 321 9103 +81 357 745 114 ...
http://www.actelion.com/UniNet/www/www_main_P.nsf/Content/me...
|
SIDR: partners_projects
Nippon Shinyaku Co., Ltd. (an extract from SIDR 10th Anniversary Report). " ' Time flies like an arrow'. I was surprised to learn that it is now 10 years ...
http://www.sidr.org/showPage.php?page=partners_projects...
|
{1} Receives Approval To Market TRISENOX(R) In Japan - News ...
SEATTLE, Oct. 25 /PRNewswire-FirstCall/ -- Cell Therapeutics, Inc. (CTI) (Nasdaq : CTIC; Nuovo Mercato) announced that Nippon Shinyaku Co., Ltd. (Nippon ...
http://www.biospace.com/news_story.aspx?NewsEntityId=1781952...
|
BioPortfolio - HISAMITSU PHARMACEUTICAL CO.LTD EMAIL AND FAX
Hisamitsu Pharmaceutical , Nippon Shinyaku Co., Ltd. Conclude Joint Development ... http://www.biospace.com/company_profile.aspx?CompanyId=83232. ...
http://www.bioportfolio.com/search/HISAMITSU_PHARMACEUTICAL_...
|
In Vitro and In Vivo Activities of NS-718, a New Lipid Nanosphere ...
LNS was developed as a drug carrier by Nippon Shinyaku Co., Ltd., Kyoto, Japan ( 20). In the present study, we investigated the efficacy of an LNS that ...
http://www.pubmedcentral.nih.gov/articlerender.fcgi?artid=89...
|
|
